Enclomiphene: What It Is and What the Evidence Says
Enclomiphene explained: an oral SERM (not a peptide) used off-label for low testosterone. How it differs from Clomid, evidence, and risks.
Anonymous user report. Not medical advice. Peptides discussed are not FDA-approved for the uses described. Editorial process →
Short answer
Enclomiphene is not a peptide. It is the trans-isomer of clomiphene (Clomid), an oral selective estrogen receptor modulator. By blocking estrogen feedback it can raise LH, FSH and the body's own testosterone while often preserving sperm counts, unlike testosterone therapy. Phase 3 trials showed testosterone rises, but the FDA did not approve it (Androxal); in the US it is generally compounded. Peptide Confessions does not publish dosing, timing, injection or sourcing guidance.
How enclomiphene works
Estrogen normally tells the hypothalamus and pituitary to ease off the signals that drive testosterone production. Enclomiphene blocks estrogen receptors in that feedback loop, so the brain sends more GnRH, and the pituitary releases more LH and FSH. LH stimulates the testes to make testosterone; FSH supports sperm production. That is why it only works when the testes themselves function, the pattern called secondary hypogonadism.
| Enclomiphene | Clomid (clomiphene) | Testosterone therapy | |
|---|---|---|---|
| What it is | Trans-isomer SERM | Mix of enclomiphene and zuclomiphene | The hormone itself |
| Raises your own testosterone | Yes, via LH | Yes, via LH | No; replaces it |
| Effect on sperm production | Generally preserved in trials | Generally preserved | Often suppressed |
| US status | Not FDA-approved | FDA-approved for female infertility; off-label in men | FDA-approved for hypogonadism |
What the evidence says
Enclomiphene was developed as Androxal. In phase 2 and phase 3 studies of men with secondary hypogonadism, it raised morning testosterone into the normal range in most participants while LH and FSH rose. A key comparison: men on topical testosterone saw sperm counts fall, while men on enclomiphene largely kept theirs. The FDA did not approve it after reviewing the phase 3 programme, which raised questions about trial design and endpoints. Long-term outcome data (heart, bone, mood, fertility over years) are lacking.
Risks people raise
Reported effects in trials and with clomiphene include headache, hot flushes, nausea, mood changes and, rarely, visual disturbances such as blurring or spots; visual symptoms need prompt medical review. Because testosterone rises, prescribers typically watch estradiol, hematocrit and lipids. Clomiphene carries warnings about blood clots, and long-term safety of enclomiphene alone is not established. See enclomiphene vs Clomid.
Who it is discussed for
It comes up mostly for men with low testosterone who want to preserve fertility, and in men's-health conversations alongside peptides such as gonadorelin and hCG. It is not a treatment for primary testicular failure, and it is not a peptide. Decisions belong with a clinician who can test hormones and sperm.
What users report
No published confession is tagged enclomiphene yet, so this page has no community pattern to show. Related men's-health stories are on peptides for testosterone.
Last reviewed
October 15, 2026.
Related topics
community guides:
More confessions from the archive
Community Q&A
- What does enclomiphene do?
- It blocks estrogen feedback in the brain so the pituitary releases more LH and FSH, which prompts the testes to make more testosterone and supports sperm production.
- Does enclomiphene affect fertility?
- In trials it generally preserved sperm production, unlike testosterone therapy, which often suppresses it. Individual results vary.
- What are the side effects of enclomiphene?
- Headache, hot flushes, nausea and mood changes are reported; visual disturbances are rare but need prompt medical review.
- Is enclomiphene a peptide?
- No. It is an oral SERM — a small-molecule drug related to Clomid — that often appears in the same men's-health conversations as peptides.
- Is enclomiphene FDA-approved?
- No. It completed phase 3 trials for secondary hypogonadism but was not approved; in the US it is typically obtained through compounding prescriptions.
- How is enclomiphene different from Clomid?
- Clomid mixes two isomers; enclomiphene is only the trans-isomer, without the longer-acting zuclomiphene that is linked to some estrogen-like effects.
- Are there enclomiphene reports on Peptide Confessions?
- Not yet. Zero published confessions are tagged enclomiphene.
- What is enclomiphene?
- Enclomiphene is the trans-isomer of clomiphene, a SERM-class drug discussed for testosterone support. It is not a peptide.
- Where are enclomiphene reports on this site?
- See the Enclomiphene topic listing and the Enclomiphene vs Clomid comparison when published. Peptide hubs remain separate.
- Does this page give dosing, prices or sourcing?
- No. We never publish dosing, prices or sourcing, and nothing here is medical advice.
Anonymous first-hand reports plus sourced context — educational only, not medical advice. Editorial policy & corrections.